Market-Moving News for June 18th
$ASNS
$ITCI
$LZB
Telecommunications Equipment
Telecommunications
Biotechnology: Pharmaceutical Preparations
Health Care
Get the next $ASNS alert in real time by email
Save time and jump to the most important pieces.
| Company | Date | Price Target | Rating | Analyst |
|---|---|---|---|---|
| 2/24/2025 | $140.00 → $132.00 | Outperform → Neutral | Mizuho | |
| 1/31/2025 | $119.00 → $132.00 | Buy → Hold | Canaccord Genuity | |
| 9/6/2024 | $68.00 → $92.00 | Neutral → Overweight | Piper Sandler | |
| 8/21/2024 | $43.00 | Buy → Neutral | Sidoti | |
| 1/3/2024 | $83.00 | Outperform | Robert W. Baird | |
| 12/11/2023 | $75.00 | Outperform | TD Cowen | |
| 4/20/2023 | $80.00 | Overweight | Morgan Stanley | |
| 8/25/2022 | Outperform → Mkt Perform | Raymond James |
Fourth quarter 2024 CAPLYTA net product sales grew to $199.2 million, representing a 51% increase over the same period in 2023 Full year 2024 CAPLYTA net product sales were $680.5 million, representing year-over-year growth of 47% The U.S. Food and Drug Administration (FDA) accepted for review the lumateperone supplemental New Drug Application (sNDA) submission for adjunctive treatment of major depressive disorder (MDD) BEDMINSTER, N.J., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced its financial result
Fiscal 2025 Third Quarter Highlights: Consolidated delivered sales of $522 million Up 4% versus prior year Operating margin on a GAAP and Non-GAAP basis improved 20 basis points versus prior yearGAAP and Non-GAAP(1) diluted EPS of $0.68Delivered sales and Non-GAAP(1) operating margin at high end of guidance rangeRetail segment sales increased 11% Fueled by same-store sales growth and independent La-Z-Boy Furniture Galleries® acquisitions, along with new storesRetail added three newly opened stores, and two newly acquired independent La-Z-Boy Furniture Galleries® stores, with one closure; and announced an additional two-store acquisition expected to close in the fourth qu
MONROE, Mich., Feb. 04, 2025 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB) will report its Fiscal 2025 Third Quarter results for the period ended January 25, 2025 after the close of trading on the New York Stock Exchange on Tuesday, February 18, 2025, and will hold its quarterly investor conference call at 8:30 a.m. Eastern Time the following day, Wednesday, February 19, 2025. The conference call will be webcast live with corresponding slides at https://lazboy.gcs-web.com/. The dial-in phone number for the live conference call will be (888) 506-0062 for persons calling from within the U.S. or Canada, and the number for international callers will be (973) 528-0011. The participant a
FREMONT, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced that it has received a follow-on order from a Hungarian utility provider to support the continued modernization of its communications network. This order builds upon Actelis' previously announced engagement in October 2023, when the company was selected to provide its advanced hybrid fiber networking technology for the utility's operations. The latest order will expand deployment across additional locations, reinforcing the network's ability to deli
FREMONT, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced it has received an order for the County of Ventura California's Systemic Countywide Signalized Intersection Improvement Project. This project will modernize and enhance the reliability of traffic signal communications across the county. As part of this initiative, Actelis' advanced networking technology will be deployed to facilitate high-speed, secure data transmission between traffic management centers and signalized intersections. The implementa
MONROE, Mich., Feb. 24, 2025 (GLOBE NEWSWIRE) -- La-Z-Boy Incorporated (NYSE:LZB), a global leader in the retail and manufacture of residential furniture, today announced that Melinda D. Whittington, Board Chair, President and Chief Executive Officer; Taylor Luebke, Senior Vice President and Chief Financial Officer; and Mark Becks, Director Investor Relations and Corporate Development will participate in a fireside chat presentation at the Raymond James 46th Annual Institutional Investors Conference held at the JW Marriott Grande Lakes in Orlando, Florida. The presentation will be webcast live on Monday March 3, 2025, at 4:00 p.m. ET and archived on the Company's investor relations website
FREMONT, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the appointment of Julie Kunstler as an independent director to its Board of Directors, effective immediately. Kunstler brings over three decades of experience in the communications components, broadband access equipment sectors, and strategic corporate positioning, along with public company board experience. Kunstler currently serves on the board of Ethernity Networks Ltd., a company traded on the London Stock Exchange, and previously served on the
With a recently announced AI-powered cyber offering, impressive government contracts, on the backdrop of new tariffs that could bolster governmental engagements with American Companies, Actelis Networks' latest strategic moves seem to reinforce its position in the $154 Billion Dollar critical infrastructure protection market; Wall street analyst recently gave Actelis a $5 price target and buy recommendation Market News Alerts Reports: Actelis Networks* (NASDAQ:ASNS), a leader in cyber-hardened networking solutions, has appointed Dr. Niel Ransom to its Board of Directors. A veteran with nearly five decades in networking, cybersecurity, and deep-tech investment, Ransom brings critical exper
FREMONT, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Actelis Networks, Inc. (NASDAQ:ASNS) ("Actelis" or the "Company"), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced the appointment of Dr. Niel Ransom, an industry veteran in networking, cybersecurity, and deep-tech investments, to its Board of Directors, effective immediately. Dr. Ransom is an industry luminary with nearly five decades of experience in networking and communications technology. He began his career at Bell Labs, contributing to industry-first innovations in applied research and product development. He later held pivotal leadership roles, including
SC 13G/A - ACTELIS NETWORKS INC (0001141284) (Subject)
SC 13G/A - Intra-Cellular Therapies, Inc. (0001567514) (Subject)
SC 13G - Intra-Cellular Therapies, Inc. (0001567514) (Subject)
4 - Intra-Cellular Therapies, Inc. (0001567514) (Issuer)
4 - Intra-Cellular Therapies, Inc. (0001567514) (Issuer)
4 - Intra-Cellular Therapies, Inc. (0001567514) (Issuer)
DFAN14A - Intra-Cellular Therapies, Inc. (0001567514) (Subject)
8-K - ACTELIS NETWORKS INC (0001141284) (Filer)
424B5 - ACTELIS NETWORKS INC (0001141284) (Filer)
Mizuho downgraded Intra-Cellular Therapies from Outperform to Neutral and set a new price target of $132.00 from $140.00 previously
Canaccord Genuity downgraded Intra-Cellular Therapies from Buy to Hold and set a new price target of $132.00 from $119.00 previously
Piper Sandler upgraded Intra-Cellular Therapies from Neutral to Overweight and set a new price target of $92.00 from $68.00 previously